Options
中草藥O007和Thymoquinoe結合對於三陰性乳腺癌細胞的抑制作用
Date Issued
2016
Author(s)
顏國城
Kuo-Cheng Yen
Advisor
蕭明文;黃俊銘
;
Abstract
乳癌是癌症婦女中最常見的類型,發病率在年齡在45-69中最高。根據國家衛福部收集的資料統計,每年大約有10000確診和2000人死亡,相當於確診的29人中有6人死亡。因此,如何治療乳癌是重要的議題。而根據實驗室以前對O007的研究,我們已經發現水萃物對乳癌細胞有抑制的作用。在這項研究中,我們使用O007和百里醌(TQ)來看細胞變化。通過MTT的方法測試,我們發現O007和TQ的有效濃度分別為400
Breast cancer is the most common type of cancer in women today, with the highest incidence rate in the age group of 45-69. According to the statistics collected by Ministry of Health and Welfare and the National Health Department, there are approximately 10000 diagnoses and 2000 deaths every year, equivalent to 29 diagnoses and 6 deaths per day on an average basis. Therefore, it is important to treat breast cancer. From our previous research on O007, we have discovered an aqueous extract has an inhibitory effect on breast cancer cells. In this study we use O007 and Thymoquinone(TQ) to see cellular changes.By using the MTT assay, we have discovered that at concentrations of 400
Subjects
中草藥
百里醌
乳癌
O007
Thymoquinone
breast cancer
Type
thesis
File(s)
No Thumbnail Available
Name
104CSMU5537006-001.zip
Size
1.71 MB
Format
Unknown
Checksum
(MD5):141c6e657c4e860062ec81b63ff327b5